Drug Therapy

Articles tagged with "Drug Therapy".

Adderall and Heart Risk: What a Mayo Clinic Trial Found

Tags: Cardiovascular Health, Drug Therapy, Evidence-Based Medicine

March 3, 2026

Can a Single Dose of Adderall Affect Your Heart?

Yes. A Mayo Clinic randomized clinical trial found that a single 25 mg dose of Adderall caused significant spikes in blood pressure, heart rate, and stress hormones in healthy young adults who had never taken the drug before. Systolic blood pressure rose from 116 to 126 mm Hg, and the heart rate response upon standing doubled.

Adderall is one of the most commonly used prescription stimulants in the United States. It is approved for treating ADHD, but off-prescription use among college students and young professionals has grown sharply over the past decade. This Mayo Clinic trial set out to measure what actually happens to the cardiovascular system when someone who has never taken Adderall uses it for the first time, and the results raise real concerns.

Efficacy of 5x5 accelerated versus conventional repetitive

Tags: Mental Health, Neurology, Drug Therapy, Evidence-Based Medicine

February 26, 2026

Can Accelerated TMS Treat Depression in Just Five Days?

Yes. A UCLA study of 175 patients found that five TMS sessions per day over five days produced comparable depression relief to the standard six-week course of daily sessions. Even patients who did not respond right away saw a 36% drop in depression scores two to four weeks later.

Transcranial magnetic stimulation, or TMS, uses magnetic pulses to stimulate specific areas of the brain involved in mood. It is one of the few treatments that works for people whose depression has not improved with medication. The problem is that standard TMS requires daily clinic visits for six weeks, which is a major barrier for many patients. This new study tested whether compressing all that treatment into just five days could work just as well.

Red Blood Cells Serve as a Primary Glucose Sink to Improve Glucose Tolerance at Altitude

Tags: Metabolic Health, Drug Therapy, Evidence-Based Medicine

February 23, 2026

Can Red Blood Cells Help Control Blood Sugar and Fight Diabetes?

Yes. Researchers at Gladstone Institutes discovered that red blood cells act as “glucose sponges” when oxygen levels drop, soaking up large amounts of sugar from the blood. A drug that mimics this effect completely reversed high blood sugar in diabetic mice, outperforming existing treatments.

People who live at higher altitudes tend to develop diabetes less often than those at sea level. Scientists have noticed this pattern for years, but nobody could fully explain why. This new study, published in Cell Metabolism in February 2026, finally cracks the code. It turns out your red blood cells have a hidden talent that switches on when oxygen gets thin.

Time-Restricted Feeding Cuts Crohn's Disease Activity in New Trial

Tags: Immune Function, Drug Therapy, Evidence-Based Medicine

February 16, 2026

Can Time-Restricted Eating Help Manage Crohn’s Disease?

Yes. The first randomized controlled trial of time-restricted feeding in Crohn’s disease found that eating within an 8-hour window for 12 weeks reduced disease activity by 40% and cut abdominal discomfort in half. Participants also lost weight, reduced visceral fat, and showed lower inflammation markers, all without changing what they ate.

Crohn’s disease is a type of inflammatory bowel disease that causes pain, cramping, and digestive problems. Most treatments involve powerful drugs that suppress the immune system. But this new trial, published in the journal Gastroenterology, suggests something much simpler could help: just changing when you eat, not what you eat. Researchers at the University of British Columbia tested whether limiting meals to an 8-hour window each day could calm the gut inflammation that drives Crohn’s symptoms.

New Pill Cuts LDL Cholesterol by 57% in Major Trial

Tags: Cardiovascular Health, Drug Therapy, Evidence-Based Medicine

February 10, 2026

Can a Daily Pill Replace Cholesterol Injections?

Yes. In a phase 3 trial, a once-daily pill called enlicitide lowered LDL cholesterol by 57.1% at 24 weeks. That matches the results of injectable PCSK9 drugs that have been available for years, but in a simple pill you take by mouth.

For millions of people who struggle to control their cholesterol with statins alone, PCSK9 inhibitors have been a game-changer. The problem is that the current options, drugs like evolocumab (Repatha) and alirocumab (Praluent), require injections every two to four weeks. Many patients skip doses or avoid them entirely because of the needle. Enlicitide could change that by putting the same type of treatment into a daily pill.

Parkinson's disease as a somato-cognitive action network disorder

Tags: Neurology, Drug Therapy, Sleep Health, Evidence-Based Medicine

February 10, 2026

Could a Newly Discovered Brain Network Explain Parkinson’s Disease?

Yes. A large international study of 863 patients found that a brain network called the somato-cognitive action network (SCAN) is central to Parkinson’s disease. When treatments targeted this network directly, symptom improvement more than doubled compared to targeting other brain areas.

Parkinson’s disease has always been hard to explain. It starts with sleep problems and digestive issues. Then it moves to tremors, stiffness, and trouble walking. It even affects thinking and motivation. No single brain region can account for all of that, and that has puzzled researchers for decades.

Breaking the Hypoxia Barrier: HBOT in Cancer Treatment

Tags: Oncology, Drug Therapy, Research Review, Evidence-Based Medicine

January 20, 2026

Can Hyperbaric Oxygen Therapy Help Cancer Treatments Work Better?

Yes. This 2025 comprehensive review found that hyperbaric oxygen therapy enhances chemotherapy, radiotherapy, and immunotherapy by addressing the low-oxygen environment inside tumors. In one study, combining HBOT with radiotherapy improved response rates from 67.4% to 95.3% for brain metastases.

Tumors create low-oxygen zones deep inside them. This low oxygen helps cancer cells resist treatment and spread. HBOT floods the body with oxygen under pressure, reaching areas that normal blood flow cannot. This review pulls together evidence from dozens of studies showing how HBOT can boost standard cancer treatments.

Hyperbaric Oxygen Therapy on Long Covid: Systematic Review

Tags: Cold Therapy, Drug Therapy, Research Review, Evidence-Based Medicine

January 20, 2026

Can Hyperbaric Oxygen Therapy Help Long COVID Symptoms?

Yes, with caveats. This systematic review of 10 studies found that HBOT can improve quality of life, fatigue, cognition, neuropsychiatric symptoms, and heart/lung function in long COVID patients. However, more rigorous trials are needed before making definitive recommendations.

Long COVID affects an estimated 20-50% of people after COVID-19 infection. Symptoms like fatigue, brain fog, and shortness of breath can last for weeks or months. Hyperbaric oxygen therapy (HBOT) has shown promise as a treatment, but how strong is the evidence?

Hyperbaric Oxygen-facilitated Cancer Treatment: Minireview

Tags: Oncology, Cold Therapy, Drug Therapy, Research Review

January 20, 2026

Can Hyperbaric Oxygen Therapy Improve Cancer Treatment?

Yes. This 2024 minireview found that hyperbaric oxygen therapy enhances multiple cancer treatments by relieving tumor hypoxia, with clinical trials showing significant effectiveness for breast, gastric, esophageal, and lung cancers. One study achieved a 99.3% tumor inhibition rate when combining HBO with other therapies.

Tumors often have very low oxygen levels inside them. This low-oxygen environment, called hypoxia, helps cancer cells survive, resist treatment, and spread. Hyperbaric oxygen therapy floods the body with oxygen under pressure, and researchers have found it can boost the effectiveness of chemotherapy, light-based treatments, and immunotherapy.

Age-dependence of Oxygen Transport Into Body Tissues and The

Tags: Exercise Recovery, Cold Therapy, Drug Therapy, Evidence-Based Medicine

January 20, 2026

Does Aging Reduce Oxygen Delivery to Your Tissues?

Yes. Oxygen transport into body tissues declines with age, primarily due to reduced heart output. However, Oxygen Multistep Therapy may counteract this decline by activating a “switch mechanism” that improves blood circulation for weeks, months, or even years.

This research describes how oxygen levels in your blood control a switching mechanism in your tiny blood vessels. When oxygen levels are high enough, your blood circulation improves and stays improved. When they fall below a critical threshold, circulation decreases for extended periods.

Effects of Intermittent Hypoxia Protocols on Physical Performance

Tags: Exercise Recovery, Drug Therapy, Research Review, Evidence-Based Medicine

January 20, 2026

Does Intermittent Hypoxia Training Improve Athletic Performance?

Yes. This umbrella review of 22 systematic reviews analyzing 487 studies and 5,333 participants found that intermittent hypoxia protocols improve both aerobic and anaerobic performance, as well as muscular strength. Different hypoxia strategies work through different mechanisms.

Intermittent hypoxia (IH) involves alternating periods of low and normal oxygen levels. What started as a concern in sleep apnea has become a powerful tool for enhancing athletic performance. This comprehensive review examined all the existing systematic reviews on the topic.

Effects of Pre-, Post- and Intra-exercise Hyperbaric Oxygen Therapy

Tags: Exercise Recovery, Drug Therapy, Research Review, Evidence-Based Medicine

January 20, 2026

Does Hyperbaric Oxygen Therapy Help Athletic Performance or Recovery?

Not when used before or after exercise. This meta-analysis of 10 studies found no significant benefits from hyperbaric oxygen therapy before or after workouts. However, using it during exercise may help muscle endurance.

Athletes and fitness enthusiasts often look for ways to boost performance and speed recovery. Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurized chamber. This systematic review examined whether timing matters for any potential benefits.